Alnylam Pharmaceuticals is based out of Cambridge. Operates a biopharmaceutical company seeking to develop and commercialize new drugs that work through a recently discovered system in cells known as RNA interference (RNAi). Initial programs are focused on an eye disease (macular degeneration) and lung disease (respiratory syncytial virus).Whalewisdom has at least 4 13G filings, and 235 Form 4 filings The firm has no submitted 13F filings and does not appear to be an investment advisor.
Contact Info
Contact information is taken directly from publicly disclosed SEC filings.
ALNYLAM PHARMACEUTICALS, INC.675 WEST KENDALL STREET
CAMBRIDGE MA 02142
Business Phone: (617) 551-8200
SEC SIC CODE:
2834-PHARMACEUTICAL PREPARATIONS
2834-PHARMACEUTICAL PREPARATIONS